Literature DB >> 12090104

[Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB)].

Rodrigo Donoso1, Juan José Mura, Mauricio López.   

Abstract

BACKGROUND: The diagnosis of acanthamoeba keratitis has increased since 1985 due to the massive use of contact lenses and a better knowledge of the disease by ophthalmologists. The use of biassociated therapy has resulted in a better prognosis and lower complication rate. AIM: To report patients with acanthamoeba keratitis treated with the association of propamidine (Brolene) and polyhexamethylbiguanide (PHMB) 0.02%. PATIENTS AND METHODS: Retrospective analysis of 27 patients (31 eyes) with acanthamoeba keratitis (bilateral in four cases), diagnosed by culture, biopsy or characteristic clinical features.
RESULTS: Ninety six percent of patients used rigid contact lenses. Acanthamoeba cultures were positive in 71% of cases. The delay in the diagnosis was between 1 and 5 months. Early treatment was possible in 29% of patients. Infection was irradicated in all cases with the biassociated therapy. A tectonic keratoplasty to treat a trophic perforation was done in eight eyes. No patient required therapeutic keratoplasty to resolve the infection. Visual acuity at the end of follow up was better than 20/40 in nine patients and in eight it was in the range of count fingers or less.
CONCLUSIONS: In patients with the clinical picture of acanthamoeba keratitis, early or late antiamoebic treatment is warranted even in the absence of positive cultures. The visual results of the treatment are highly dependent on the precocity of treatment. Prevention is imperative and is based on a strict contact lens hygiene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12090104

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  5 in total

Review 1.  Pathogenesis of acanthamoeba keratitis.

Authors:  Noorjahan Panjwani
Journal:  Ocul Surf       Date:  2010-04       Impact factor: 5.033

2.  Polyhexamethylene biguanide functionalized cationic silver nanoparticles for enhanced antimicrobial activity.

Authors:  Sumaira Ashraf; Nasrin Akhtar; Muhammad Afzal Ghauri; Muhammad Ibrahim Rajoka; Zafar M Khalid; Irshad Hussain
Journal:  Nanoscale Res Lett       Date:  2012-05-24       Impact factor: 4.703

3.  The resistance of the yeast Saccharomyces cerevisiae to the biocide polyhexamethylene biguanide: involvement of cell wall integrity pathway and emerging role for YAP1.

Authors:  Carolina Elsztein; Rodrigo M de Lucena; Marcos A de Morais
Journal:  BMC Mol Biol       Date:  2011-08-19       Impact factor: 2.946

4.  The effect of the disulfideisomerase domain containing protein in the defense against polyhexamethylene biguanide of highly tolerant Acanthamoeba at the trophozoite stage.

Authors:  Fu-Chin Huang; Tao-Shen Liu; Sung-Chou Li; Min-Hsiu Shih; Jyh-Wei Shin; Wei-Chen Lin
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-11-14       Impact factor: 4.077

Review 5.  Cationic antimicrobial polymers and their assemblies.

Authors:  Ana Maria Carmona-Ribeiro; Letícia Dias de Melo Carrasco
Journal:  Int J Mol Sci       Date:  2013-05-10       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.